<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Screening using the fecal occult blood test (FOBT) has been shown to reduce mortality from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the impact of repeated screening on the detection of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and on false-negative results is unclear </plain></SENT>
<SENT sid="2" pm="."><plain>Thus, we conducted a case-control study </plain></SENT>
<SENT sid="3" pm="."><plain>Male patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, <z:mpath ids='MPATH_270'>adenoma</z:mpath> with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (<z:mpath ids='MPATH_491'>polyp</z:mpath> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>) or <z:mpath ids='MPATH_490'>adenomatous polyps</z:mpath>, detected through screening using the FOBT between January 1996 and December 2007, were identified and their screening history was obtained </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with interval <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, diagnosed within 1 year of the most recent FOBT, were also included </plain></SENT>
<SENT sid="5" pm="."><plain>We identified 27 patients with interval <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, 156 with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, 266 with <z:mpath ids='MPATH_491'>polyp</z:mpath> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, and 3566 with <z:mpath ids='MPATH_490'>adenomatous polyps</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>Three controls for each patient with colorectal or interval <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> were selected randomly from patients with <z:mpath ids='MPATH_490'>adenomatous polyp</z:mpath> and <z:mpath ids='MPATH_491'>polyp</z:mpath> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, matched by diagnosis year and birth year </plain></SENT>
<SENT sid="7" pm="."><plain>Odds ratios (ORs) for the diagnosis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> or interval <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> were estimated based on the frequency of screening </plain></SENT>
<SENT sid="8" pm="."><plain>There was no apparent difference in the frequency of screening between the patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and the controls (<z:mpath ids='MPATH_491'>polyp</z:mpath> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and patients with <z:mpath ids='MPATH_490'>adenomatous polyp</z:mpath>) </plain></SENT>
<SENT sid="9" pm="."><plain>The OR (95% confidence interval) for being diagnosed with interval <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> after three or more screenings compared with a single screening was 0.07 (0.02-0.32), and the OR was 0.18 (0.05-0.66) compared with two screenings </plain></SENT>
<SENT sid="10" pm="."><plain>The results of this study showed that repeated screening reduces the risk of being diagnosed with interval <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>